WHO ICTRP trial
Effect of Mesalazine plus nifedipine suppositoires (Antrorect) in functional…
EUCTR2010-023938-23-IT · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2010-023938-23-IT |
|---|---|
| Public title | Effect of Mesalazine plus nifedipine suppositoires (Antrorect) in functional ano-rectal pain disorders: a pilot randomized double-blind placebo-controlled study. - ND |
| Scientific title | Effect of Mesalazine plus nifedipine suppositoires (Antrorect) in functional ano-rectal pain disorders: a pilot randomized double-blind placebo-controlled study. - ND |
| Primary sponsor | BRACCO |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Italy |
| Conditions | Functional ano-rectal pain disorders MedDRA version: 9.1 Level: LLT Classification code 10058446 |
| Interventions | Product Name: Antrorect Pharmaceutical Form: Suppository Current Sponsor code: Antrorect Concentration unit: g gram(s) Concentration type: equal Concentration number: 1- Pharmaceutical form of the placebo: Suppository Route of… |
| Registration date | Dec 24, 2010 |
| Secondary IDs | Antrorect/02/09 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: